Phase I trial of adjuvant pembrolizumab after radiation therapy for lung-intact malignant pleural mesothelioma

被引:0
|
作者
Ning, M. S. [1 ]
Gandhi, S. [1 ]
Gomez, D. R. [2 ]
Chang, J. Y. [1 ]
Blumenschein, G. [3 ]
Rice, D. [4 ]
O'Reilly, M. [1 ]
Sepesi, B. [5 ]
Lin, S. H. H. [1 ]
Liao, Z. [1 ]
Le, X. [3 ]
Byers, L. A. [3 ]
Mehran, R. [4 ]
Hofstetter, W. [4 ]
Hernandez, M. [6 ]
Chen, Y-S. [1 ]
Jeter, M. [1 ]
Tsao, A. S. [3 ]
机构
[1] UT MD Anderson Canc Ctr, Radiat Oncol, Houston, TX USA
[2] MSKCC Mem Sloan Kettering Canc Ctr, Radiat Oncol, New York, NY USA
[3] UT MD Anderson Canc Ctr, Thorac Head & Neck Med Oncol, Houston, TX USA
[4] UT MD Anderson Canc Ctr, Thorac & Cardiovasc Surg, Houston, TX USA
[5] Cardiothorac & Vasc Surg Associates Aurora, HealthOne Phys Grp, Aurora, CO USA
[6] UT MD Anderson Canc Ctr, Biostat, Houston, TX USA
关键词
D O I
10.1016/j.annonc.2024.08.1997
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1915P
引用
收藏
页码:S1115 / S1115
页数:1
相关论文
共 50 条
  • [41] PHASE-II TRIAL OF VINDESINE IN MALIGNANT PLEURAL MESOTHELIOMA
    BOUTIN, C
    IRISSON, M
    GUERIN, JC
    ROEGEL, E
    PARAMELLE, B
    BRAMBILLA, C
    JEANNIN, L
    DABOUIS, G
    LECAER, H
    VIALLAT, JR
    CANCER TREATMENT REPORTS, 1987, 71 (02): : 205 - 206
  • [42] Hemithoracic radiation after extrapleural pneumonectomy for malignant pleural mesothelioma
    Yajnik, S
    Rosenzweig, KE
    Mychalczak, B
    Krug, L
    Flores, R
    Hong, L
    Rusch, VW
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 56 (05): : 1319 - 1326
  • [43] Malignant pleural mesothelioma after radiation treatment for Hodgkin lymphoma
    Vandenbos, F.
    Figueredo, M.
    Dumon-Gubeno, M-C
    Nicolle, I.
    Tarhini, A.
    Butori, C.
    Mouroux, J.
    REVUE DE PNEUMOLOGIE CLINIQUE, 2013, 69 (05) : 291 - 293
  • [44] Questions Regarding the Randomized Phase II Trial of Defactinib as Maintenance Therapy in Malignant Pleural Mesothelioma
    Masuda, Ken
    Ishiki, Hiroto
    Oyamada, Shunsuke
    Shimizu, Masaki
    Kiuchi, Daisuke
    Satomi, Eriko
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (25) : 2293 - +
  • [45] Phase II trial of vinorelbine and oxaliplatin as first-line therapy in malignant pleural mesothelioma
    Fennell, DA
    Steele, JPC
    Shamash, J
    Sheaff, MT
    Evans, MT
    Goonewardene, TI
    Nystrom, ML
    Gower, NH
    Rudd, RM
    LUNG CANCER, 2005, 47 (02) : 277 - 281
  • [46] PROLONGED SURVIVAL OF PATIENTS WITH LOCALISED MALIGNANT PLEURAL MESOTHELIOMA AFTER HIGH DOSE HEMITHORACIC RADIOTHERAPY TO AN INTACT LUNG
    Feigen, M.
    Lawlor, M.
    Lee, S. T.
    Hamilton, C.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (06) : S82 - S82
  • [47] Pembrolizumab in the Treatment of Patients with Malignant Pleural Mesothelioma Following Progression After Initial Chemotherapy
    Cengel, K.
    Katz, S.
    Roshkovan, L.
    Mcnulty, S.
    Lian, J.
    Aleynick, D.
    Culligan, M.
    Friedberg, J.
    Singhal, S.
    Li, C. Simone
    Ciunci, C.
    Marmarelis, M.
    Alley, E.
    Langer, C.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S267 - S268
  • [48] Trimodality therapy for malignant pleural mesothelioma: results from an EORTC phase II multicentre trial
    Van Schil, P. E.
    Baas, P.
    Gaafar, R.
    Maat, A. P.
    Van de Pol, M.
    Hasan, B.
    Klomp, H. M.
    Abdelrahman, A. M.
    Welch, J.
    van Meerbeeck, J. P.
    EUROPEAN RESPIRATORY JOURNAL, 2010, 36 (06) : 1362 - 1369
  • [49] Targeting Polyamines as Potential Adjuvant Therapy in Malignant Pleural Mesothelioma Xenograft Models
    Lam, S. K.
    Yan, S.
    Xu, S.
    Ho, J. C.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S749 - S750
  • [50] Hemithoracic radiation therapy after extrapleural pneumonectomy for malignant pleural mesothelioma: Applicable to all and by all?
    Haas, Rick
    Baas, Paul
    JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2015, 59 (03) : 353 - 354